Ascendis to Regain Rights to TransCon® Technology in Metabolic and Cardiovascular Diseases
Go back to Ascendis to Regain Rights to TransCon® Technology in Metabolic and Cardiovascular Diseases| Asianada, Inc. (NASDAQ: ASND) | Delayed: 241.86 +2.96 (1.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $238.90 | 52 Week High | $21.79 | |||
| Open | $239.38 | 52 Week Low | $11.92 | |||
| Day High | $243.26 | P/E | N/A | |||
| Day Low | $236.87 | EPS | $-0.07 | |||
| Volume | 356,433 | |||||



